156 related articles for article (PubMed ID: 22118625)
21. RNA binding protein RALY promotes Protein Arginine Methyltransferase 1 alternatively spliced isoform v2 relative expression and metastatic potential in breast cancer cells.
Bondy-Chorney E; Baldwin RM; Didillon A; Chabot B; Jasmin BJ; Côté J
Int J Biochem Cell Biol; 2017 Oct; 91(Pt B):124-135. PubMed ID: 28733251
[TBL] [Abstract][Full Text] [Related]
22. Understanding the Intersections between Metabolism and Cancer Biology.
Vander Heiden MG; DeBerardinis RJ
Cell; 2017 Feb; 168(4):657-669. PubMed ID: 28187287
[TBL] [Abstract][Full Text] [Related]
23. The hnRNP family: insights into their role in health and disease.
Geuens T; Bouhy D; Timmerman V
Hum Genet; 2016 Aug; 135(8):851-67. PubMed ID: 27215579
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus-mediated ubiquitination alters protein-RNA binding and aids viral RNA processing.
Herrmann C; Dybas JM; Liddle JC; Price AM; Hayer KE; Lauman R; Purman CE; Charman M; Kim ET; Garcia BA; Weitzman MD
Nat Microbiol; 2020 Oct; 5(10):1217-1231. PubMed ID: 32661314
[TBL] [Abstract][Full Text] [Related]
25. The RNA binding protein RALY suppresses p53 activity and promotes lung tumorigenesis.
Hu H; Zhao K; Fang D; Wang Z; Yu N; Yao B; Liu K; Wang F; Mei Y
Cell Rep; 2023 Apr; 42(4):112288. PubMed ID: 36952348
[TBL] [Abstract][Full Text] [Related]
26. RALY regulate the proliferation and expression of immune/inflammatory response genes via alternative splicing of FOS.
Liang Z; Rehati A; Husaiyin E; Chen D; Jiyuan Z; Abuduaini B
Genes Immun; 2022 Dec; 23(8):246-254. PubMed ID: 35941292
[TBL] [Abstract][Full Text] [Related]
27. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
28. Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism.
Lee J; Yesilkanal AE; Wynne JP; Frankenberger C; Liu J; Yan J; Elbaz M; Rabe DC; Rustandy FD; Tiwari P; Grossman EA; Hart PC; Kang C; Sanderson SM; Andrade J; Nomura DK; Bonini MG; Locasale JW; Rosner MR
Nature; 2019 Apr; 568(7751):254-258. PubMed ID: 30842661
[TBL] [Abstract][Full Text] [Related]
29. Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer.
Xu J; Liu Y; Li Y; Wang H; Stewart S; Van der Jeught K; Agarwal P; Zhang Y; Liu S; Zhao G; Wan J; Lu X; He X
Nat Nanotechnol; 2019 Apr; 14(4):388-397. PubMed ID: 30804480
[TBL] [Abstract][Full Text] [Related]
30.
Niu Y; Wan A; Lin Z; Lu X; Wan G
Acta Pharm Sin B; 2018 Oct; 8(6):833-843. PubMed ID: 30505654
[No Abstract] [Full Text] [Related]
31. RNA modifications modulate gene expression during development.
Frye M; Harada BT; Behm M; He C
Science; 2018 Sep; 361(6409):1346-1349. PubMed ID: 30262497
[TBL] [Abstract][Full Text] [Related]
32. miRNA targeting and alternative splicing in the stress response - events hosted by membrane-less compartments.
Kucherenko MM; Shcherbata HR
J Cell Sci; 2018 Feb; 131(4):. PubMed ID: 29444950
[TBL] [Abstract][Full Text] [Related]
33. Molecular basis for the specific and multivariant recognitions of RNA substrates by human hnRNP A2/B1.
Wu B; Su S; Patil DP; Liu H; Gan J; Jaffrey SR; Ma J
Nat Commun; 2018 Jan; 9(1):420. PubMed ID: 29379020
[TBL] [Abstract][Full Text] [Related]
34. Promoter-bound METTL3 maintains myeloid leukaemia by m
Barbieri I; Tzelepis K; Pandolfini L; Shi J; Millán-Zambrano G; Robson SC; Aspris D; Migliori V; Bannister AJ; Han N; De Braekeleer E; Ponstingl H; Hendrick A; Vakoc CR; Vassiliou GS; Kouzarides T
Nature; 2017 Dec; 552(7683):126-131. PubMed ID: 29186125
[TBL] [Abstract][Full Text] [Related]
35. Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia.
Hattori A; Tsunoda M; Konuma T; Kobayashi M; Nagy T; Glushka J; Tayyari F; McSkimming D; Kannan N; Tojo A; Edison AS; Ito T
Nature; 2017 May; 545(7655):500-504. PubMed ID: 28514443
[TBL] [Abstract][Full Text] [Related]
36. The cancer epigenome: Concepts, challenges, and therapeutic opportunities.
Dawson MA
Science; 2017 Mar; 355(6330):1147-1152. PubMed ID: 28302822
[TBL] [Abstract][Full Text] [Related]
37. Amplification of USP13 drives ovarian cancer metabolism.
Han C; Yang L; Choi HH; Baddour J; Achreja A; Liu Y; Li Y; Li J; Wan G; Huang C; Ji G; Zhang X; Nagrath D; Lu X
Nat Commun; 2016 Nov; 7():13525. PubMed ID: 27892457
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneous Ribonucleoprotein K (hnRNP K) Binds miR-122, a Mature Liver-Specific MicroRNA Required for Hepatitis C Virus Replication.
Fan B; Sutandy FX; Syu GD; Middleton S; Yi G; Lu KY; Chen CS; Kao CC
Mol Cell Proteomics; 2015 Nov; 14(11):2878-86. PubMed ID: 26330540
[TBL] [Abstract][Full Text] [Related]
39. HNRNPA2B1 Is a Mediator of m(6)A-Dependent Nuclear RNA Processing Events.
Alarcón CR; Goodarzi H; Lee H; Liu X; Tavazoie S; Tavazoie SF
Cell; 2015 Sep; 162(6):1299-308. PubMed ID: 26321680
[TBL] [Abstract][Full Text] [Related]
40. Functional Anatomy of the Human Microprocessor.
Nguyen TA; Jo MH; Choi YG; Park J; Kwon SC; Hohng S; Kim VN; Woo JS
Cell; 2015 Jun; 161(6):1374-87. PubMed ID: 26027739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
